Why is Vivo Bio Tech falling/rising?

As of 20-Aug, Vivo Bio Tech Ltd. is experiencing a rise in its stock price, currently at Rs 40.48, reflecting an increase of Rs 3.22 or 8.64%. The stock has shown strong performance today, outperforming its sector by 9.06% and achieving a consecutive gain over the last two days with a total return of 10.27%. It reached an intraday high of Rs 43.3, indicating significant volatility with an intraday fluctuation of 7.85%. Over the past week, the stock has risen by 8.12%, and year-to-date, it has increased by 8.58%. Positive financial results, including a 163.74% growth in profit after tax and record net sales, have contributed to the stock's upward momentum. However, a decrease in promoter holding to 39.06% and weak long-term fundamentals, such as a negative CAGR growth in net sales over the last five years, present concerns that could temper investor enthusiasm.
In the broader market context, Vivo Bio Tech's recent performance has significantly outpaced the benchmark Sensex, which has only increased by 1.64% over the past week. The stock's ability to generate a return of 6.53% over the past year, compared to the Sensex's 1.31%, further highlights its strong relative performance. Despite these positive short-term indicators, the company's long-term challenges, including a poor EBIT to interest ratio and low profitability per unit of shareholders' funds, could impact future investor sentiment. Overall, while the stock is currently rising due to favorable short-term results and market performance, underlying weaknesses may pose risks moving forward.